3-D Pharmacophores in drug discovery

被引:176
作者
Mason, JS
Good, AC
Martin, EJ
机构
[1] Bristol Myers Squibb Co, Struct Biol & Modeling, Princeton, NJ 08543 USA
[2] Bristol Myers Squibb Co, Wallingford, CT 06492 USA
[3] Chiron Corp, Computat Chem, Emeryville, CA 94608 USA
关键词
D O I
10.2174/1381612013397843
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In this chapter we review the use of 3-D pharmacophores in drug discovery. Recent advances are highlighted, including the application of pharmacophore descriptors generated both from ligands and protein binding sites. The application of 3-D pharmacophore fingerprints as molecular descriptors for similarity and diversity applications such as virtual screening, library design and QSAR is discussed. In addition, we highlight the quantification of structure-based diversity using site-derived fingerprints, and review virtual screening methods using both single refined hypotheses and the fingerprints of multiple potential hypotheses. Further, we discuss methods that take protein flexibility and molecular shape-into account.
引用
收藏
页码:567 / 597
页数:31
相关论文
共 155 条
[1]   An efficient implementation of distance-based diversity measures based on k-d trees [J].
Agrafiotis, DK ;
Lobanov, VS .
JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES, 1999, 39 (01) :51-58
[2]   Stochastic algorithms for maximizing molecular diversity [J].
Agrafiotis, DK .
JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES, 1997, 37 (05) :841-851
[3]   On the use of information theory for assessing molecular diversity [J].
Agrafiotis, DK .
JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES, 1997, 37 (03) :576-580
[4]   SYBYL line notation (SLN): A versatile language for chemical structure representation [J].
Ash, S ;
Cline, MA ;
Homer, RW ;
Hurst, T ;
Smith, GB .
JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES, 1997, 37 (01) :71-79
[5]   New perspectives in lead generation .2. Evaluating molecular diversity [J].
Ashton, MJ ;
Jaye, MC ;
Mason, JS .
DRUG DISCOVERY TODAY, 1996, 1 (02) :71-78
[6]   Selective endothelin a receptor antagonists. 3. Discovery and structure-activity relationships of a series of 4-phenoxybutanoic acid derivatives [J].
Astles, PC ;
Brealey, C ;
Brown, TJ ;
Facchini, V ;
Handscombe, C ;
Harris, NV ;
McCarthy, C ;
McLay, IM ;
Porter, B ;
Roach, AG ;
Sargent, C ;
Smith, C ;
Walsh, RJA .
JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (15) :2732-2744
[7]   Identification of common functional configurations among molecules [J].
Barnum, D ;
Greene, J ;
Smellie, A ;
Sprague, P .
JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES, 1996, 36 (03) :563-571
[8]   Binning schemes for partition-based compound selection [J].
Bayley, MJ ;
Willett, P .
JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 1999, 17 (01) :10-18
[9]   A FAST AND EFFICIENT METHOD FOR 2D AND 3D MOLECULAR SHAPE-DESCRIPTION [J].
BEMIS, GW ;
KUNTZ, ID .
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 1992, 6 (06) :607-628
[10]   A novel electron-conformational approach to molecular modeling for QSAR by identification of pharmacophore and anti-pharmacophore shielding [J].
Bersuker, IB ;
Bahceci, S ;
Boggs, JE ;
Pearlman, RS .
SAR AND QSAR IN ENVIRONMENTAL RESEARCH, 1999, 10 (2-3) :157-173